Latest news and press releases
Bracco Announces $230 Million Investment in First U.S. Manufacturing Facility for Injectable Contrast Media
28 October 2026
Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for for VueJect®, the First Dedicated Ultrasound Contrast Delivery System
11 August 2026
Bracco Launches BubbleGen™ Early Access Program for Microbubble-Based Cell Selection and Activation at ISCT
05 May 2026
Bracco Imaging and NYU Langone Health Announce Strategic Alliance Agreement to Advance Medical Imaging Innovation
20 April 2026
Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation Technologies
04 February 2026
The European Commission extended the Marketing Authorisation for VUEWAY® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age
27 January 2026
Media contacts
If you are a journalist and you need more information about Bracco Imaging Group.
Bracco Imaging S.p.A.
Media Relations
Via Egidio Folli 50, 20134 - Milan, Italy
Tel. +39 (02) 21772279
Contact by email: [email protected]
Contact us
Please fill out the form below and we will get back to you